Eterna (ERNA) Therapeutics announced a successful inaugural meeting of its newly formed Scientific Advisory Board, SAB. The meeting brought together leading experts in cell therapy to evaluate preclinical advances, address key scientific questions, refine the company’s research and development priorities, and discuss the roadmap to human clinical trials. The board consists of leaders in the field, including: Michael Andreeff; Christopher Rohde; Blythe Sather; Jerome B. Zeldis
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ERNA: